Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation

No imaging methodology currently exists to monitor viable islet mass after clinical intraportal islet transplantation. We investigated the potential of the endocrine positron emission tomography (PET) marker [(11)C]5-hydroxytryptophan ([(11)C]5-HTP) for this purpose. In a preclinical proof-of-concep...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Olof, Selvaraju, Ramkumar, Eich, Torsten, Willny, Mariam, Brismar, Torkel B., Carlbom, Lina, Ahlström, Håkan, Tufvesson, Gunnar, Lundgren, Torbjörn, Korsgren, Olle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Technological Advances
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001185/
https://www.ncbi.nlm.nih.gov/pubmed/27325286
http://dx.doi.org/10.2337/db16-0222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5001185/
https://www.ncbi.nlm.nih.gov/pubmed/27325286
http://dx.doi.org/10.2337/db16-0222

Ejemplares similares